3[1]Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms [J]. Nature, 2001;409:928-933.
4[2]Evans WE, Johnson JA. Pharmacogenomics: the inherited basis for interindividual differences in drug response [J]. Ann Rev Genomics Hum Genet, 2001;2:9-39.
5[3]Mcleod HL, Evans WE. Pharmacogenomics: unlocking the human genome for better drug therapy [J]. Ann Rev Pharmacol Toxicol,2001;41:101-121.
6[4]Dishy V, Sofowora GG, Xie HG, et al. The effect of common polymorphisms of the β2-adrenergic receptor on agonist-mediated vascular desensitization [J]. New Engl J Med, 2001;345:1030-1035.
7[5]Evans WE, Hon YY, Bomgaars L, et al. Preponderance ofthiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol, 200 1;19:2293-2301.
8[6]Liggett SB. β2-adrenergic receptor pharmacogenetics [J]. Am J Respir Crit Care Med, 2000;161(Suppl):S197-S201.
9[7]Israel E, Drazen JM, Liggett SB, et al. Effect of polymorphism of the β2-adrenergic receptor on response to regular use of albuterol in asthma[J]. Int Arch Allergy Immunol, 2001;124:183-186.
10[8]Sesti F, Abbott GW, Wei J, et al. A common polymorphism associated with antibiotic-induced cardiac arrhythmia [J]. Proc Natl Acad Sci USA, 2000;97:10613-10618.
